BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2017
View Archived Issues
Fujifilm to begin clinical testing of FF-10832 for advanced solid tumors next year
Read More
FDA issues refusal to file letter for SteadyMed's Trevyent NDA
Read More
Akcea announces NDA submission for volanesorsen in familial chylomicronemia syndrome
Read More
Bayer submits BLA to FDA for BAY-94-9027
Read More
Sunovion files NDA for dasotraline to treat ADHD
Read More
Daiichi Sankyo terminates agreement with Charleston Laboratories
Read More
Topline results from Asian REDUCER trial of mirogabalin in diabetic peripheral neuropathic pain
Read More
Sumitomo Dainippon Pharma submits an application in Japan for an additional indication for Trerief
Read More
Bristol-Myers Squibb explores adaptor-associated kinase 1 as a target for neuropathic pain
Read More
Thermo Fisher forms European Immuno-Oncology Consortium
Read More
Serum APEX found a marker of myocarditis severity
Read More
European Commission approves pediatric formulation of Mimpara
Read More
Mochida compound shows effective targeting of FFAR1 for diabetes
Read More
Horizon Discovery completes acquisition of GE Healthcare Dharmacon
Read More
Aptevo and MorphoSys end partnership for MOR-209
Read More
FDA awards fast track designation to Iovance's LN-144 for advanced melanoma
Read More
Taisho Pharmaceutical presents 20-HETE synthase inhibitors
Read More
Heptares begins leukotriene receptor modulator collaboration with Juntendo University
Read More
ImMAGE Biotherapeutics terminates operations
Read More
Roche and Genentech patent new Janus kinase inhibitors
Read More
Sprint Bioscience AB divulges PIK3C3 inhibitors
Read More
RegeneRx completes license expansion agreement with GtreeBNT for RGN-137
Read More
Oragenics initiates phase II trial of AG-013 for oral mucositis
Read More
Janssen Vaccines & Prevention BV patent adenoviral vectors for treating malaria
Read More
Penn State Research Foundation divulges CCK2 receptor-targeting DNA aptamers
Read More
Novel compounds target MYC via G-quadruplex in the promoter region
Read More
Janssen Biotech terminates duvortuxizumab agreement with MacroGenics
Read More
Novel susceptibility loci identified for aortic aneurysm in Japanese individuals
Read More